Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Acute Confusional Senile Dementia

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Acute Confusional Senile Dementia in 2 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cherny, RA1
Legg, JT1
McLean, CA1
Fairlie, DP1
Huang, X1
Atwood, CS1
Beyreuther, K1
Tanzi, RE1
Masters, CL1
Bush, AI1
Ho, LH1
Ratnaike, RN1
Zalewski, PD1

Other Studies

2 other studies available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Acute Confusional Senile Dementia

ArticleYear
Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion.
    The Journal of biological chemistry, 1999, Aug-13, Volume: 274, Issue:33

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Chelating Agents; Copper; Egtazic Acid; Ethylenedia

1999
Involvement of intracellular labile zinc in suppression of DEVD-caspase activity in human neuroblastoma cells.
    Biochemical and biophysical research communications, 2000, Feb-05, Volume: 268, Issue:1

    Topics: Alzheimer Disease; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Chelating Agents; Coumarins;

2000